ZEB1 and ovarian carcinoma: Moreover, heterozygous knockout of ZEB1 was reported to mitigate the pro-malignant influence of peritoneal macrophages on ovarian cancer cells directly, and homozygous loss of ZEB1 in myeloid cells impaired full activation and recovery from inflammation as well as the response to viral infection in mice29,35,36.